Topic: GENERIC
43 results were found.
Generic pharmaceuticals market expected to reach $682.9 billion - March 21, 2023
Hetero's Nirmacom is world's first generic version of COVID-19 oral drug Paxlovid to receive WHO prequalificat - December 27, 2022
Accord Healthcare launches generic doxorubicin pegylated liposomal concentrate - August 8, 2022
Worldwide generic drugs industry is projected to reach $507.8 billion - April 5, 2022
35 generic drugmakers sign on to make cheap version of Pfizer COVID-19 pill - March 18, 2022
Perrigo completes divestiture of generic Rx business for $1.55 billion - July 7, 2021
Perrigo sells Generic Rx Pharmaceuticals for $1.55 billion - March 1, 2021
Court unseals latest U.S. generic drug complaint, including excerpts from Diary of Collusion - January 30, 2021
Commission fines Teva and Cephalon €60.5 million for delaying entry of cheaper generic medicine - November 30, 2020
India starts producing generic Remdesivir amid pandemic - June 23, 2020
Pennsylvania AG Shapiro: Generic drug manufacturers are fixing prices, hurting consumers - June 10, 2020
Otsuka Canada Pharmaceutical resolved generic drugs problem - April 3, 2020
Ex Sandoz executive admits role in generic drug price fixing plot - February 19, 2020
Novartis CEO says they will not sell Sandoz generics unit - July 27, 2019
Prices of Canadian generic medicines below international average - June 1, 2019
FDA approves first generic naloxone nasal spray to treat opioid overdose - April 20, 2019
FDA approves first generic version of EpiPen - August 16, 2018
Sanofi in talks to sell generics arm to Advent for $2.4 billion - April 17, 2018
Teva to launch generic Viagra in U.S. - December 12, 2017
Buyout firms buys German generics group Stada for $6.2 billion - August 19, 2017
GlaxoSmithKline awarded $235 million in U.S. generic drug case - June 22, 2017
Generic vaccine BCG shows potential to reverse advanced type 1 diabetes - June 14, 2017
Germany's Fresenius in talks to buy generic drugmaker Akorn - April 8, 2017
Judge says Mylan may make generics, Teva says no way - January 31, 2017
Court says Eli Lilly may block Teva's generic - January 12, 2017
Teva: Dipankar Bhattacharjee new CEO of Global Generic Medicines - December 6, 2016
Mylan to launch generic EpiPen at 50% discount - August 29, 2016
Generic biologic drugs seem as effective as originals - August 3, 2016
Teva Pharma completes Actavis Generics acquisition - August 2, 2016
Impax names Douglas S. Boothe president of generics division - July 25, 2016
Impax Labs to buy generics from Teva and Allergan for $586 million - June 22, 2016
Wal-Mart to distribute McKesson's generic drugs - May 16, 2016
FTC sues Endo Pharmaceuticals, 7 others for blocking lower-cost generics - March 31, 2016
Teva sees close of $40.5 billion Allergan generics deal by June - March 16, 2016
EU approves acquisition of Allergan Generics by Teva with conditions - March 10, 2016
Zoetis sells plant and generics in India to Zydus Cadila - January 6, 2016
Eisai to buy Chinese generic pharma company Liaoning Tianyi - December 2, 2015
Generic drugs are as effective as branded and cost less - November 26, 2015
Teva secures $33.75 billion for acquisition of Allergan's generic business - July 31, 2015
Teva withdraws from Mylan, will buy Allergan Generics in $40.5 billion transaction - July 27, 2015
ANI Pharmaceuticals buys 22 generic drugs from Teva for $25 million - July 14, 2015
Teva names president and CEO of Global Generic Medicines Group - June 3, 2014
Tris Pharma hires president for generic pharmaceuticals business - June 21, 2013